What are the risks of cannabis use?
On April 26, the United States reclassified cannabis from a Schedule I controlled substance, which lacks any medical benefits, to a Schedule III controlled substance, which has accepted medical uses and lower potential for misuse than a Schedule I substance. Over the past two decades, cannabis has…
Dispensaries are recommending cannabis for pain and sleep — with no evidence, UCSF study finds
The work of SSRI cofund Louisa Holmes, associate professor of geography & demography, was recently featured in this article published in the San Francisco Chronicle. By Catherine Ho, Staff Writer, for the San Francisco Chronicle Cannabis dispensaries in the Bay Area often recommend specific…
News Topics:
Substance Use
Marijuana
Q&A: What would reclassifying marijuana mean for medical research?
UNIVERSITY PARK, Pa. — There may be a major change in national drug policy coming soon. The Trump administration is considering reclassifying marijuana from a Schedule I to a Schedule III substance. The change in classification was proposed in 2024 under the Biden administration, following a…
News Topics:
Marijuana
Public Policy